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GENERAL SURGERY
Burn wound infection due to Pseudomonas aeruginosa poses 
a significant challenge in terms of systemic sepsis, graft loss, 
prolonged hospital stay, and even increased mortality.[1-12] Armour 
et al. reported on 48 adult patients with gentamicin-resistant 
P. aeruginosa colonisation.[1] Compared with case-matched 
controls, this cohort required a twofold increase in grafting 
procedures as well as an average of 15 days’ longer hospital stay.[1] 
Geyik and colleagues reported the only specific series to detail the 
effect of P. aeruginosa in children.[2] They found a 65% frequency 
of wound colonisation, with systemic sepsis in 7.2% which, when 
associated with bacteraemia, was associated with an 80% mortality. 
Red Cross War Memorial Children's Hospital (RCH) Cape 
Town, has the only dedicated paediatric burns unit in the Western 
Cape province of South Africa. It serves a population of over 5.8 
million and annually admits an average of 1 100 burns patients. 
The frequency, systemic and local therapy, and morbidity of 
P. aeruginosa infection in the burns unit of RCH have not been 
documented previously. This study aims to address this deficit. 
Methods
The cohort for analysis was accrued from all admissions to the 
burns unit at RCH between April 2007 and January 2010. The 
unit admits children with partial-thickness burns greater than 
10% total body surface area (TBSA), and all patients with full-
thickness burns, circumferential limb involvement, facial burns, 
perineal burns and burns to hands or feet. The patients are treated 
according to standard management protocols. The standard of 
care during the study period was to treat wounds infected with 
P. aeruginosa (even if clinically suspected and not yet proven 
with a positive swab) with daily soaks with an unbuffered sodium 
hypochlorite solution,[13] after which the wounds were dressed with 
Flamazine dressings. Chlorhexidine was substituted for Flamazine 
if an organism resistant to Flamazine was isolated. 
Numbers of P. aeruginosa wound isolates and isolates from 
other sites were noted for the whole cohort. For patients with 
clinically significant P. aeruginosa burn wound infection (defined 
as the combination of a positive isolate from a wound swab 
and the wound characteristics of excessive slough, erythema, 
green discoloration and the characteristic smell), the following 
information was recorded from the case records: patient 
demographics, percentage of TBSA of the burn, time to acquisition 
of infection, Biobrane, allograft and autologous skin graft loss, 
number of theatre visits, wound dressings and their frequency 
of application, use of antimicrobial agents, time to eradication of 
infection, delay to definitive skin grafting, and overall hospital 
stay. Microbiological data recorded were the resistance patterns of 
P. aeruginosa isolates to topical and systemic antimicrobial agents. 
Results
Patient demographics
During the 36-month study period, 2 632 patients were admitted 
to the burns unit at RCH, 2 791 bacteriology samples were sent 
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for microscopy, culture and sensitivity and 906 had an organism 
isolated; of these samples, 406 (14.5% of the total) were positive for 
P. aeruginosa. 
Thirty-four patients were recorded to have clinically significant 
Pseudomonas burn wound infection, yielding a frequency of 1.3%. 
Three patient records had been lost and could not be reviewed. 
Thirty-one patients were therefore analysed.
Twenty of the 31 patients were male and 11 were female. The 
mean age of those who developed P. aeruginosa infection was 
3 years (range 4 months - 10 years). The mean TSBA involved was 
27% (range 8 - 65%). 
The mean time between admission and diagnosis of 
Pseudomonas infection was 10 days (range 1 - 34 days), that 
between a positive culture and initiation of appropriate 
management 2 days (range 0 - 9 days), and that between diagnosis 
and negative culture 13 days (range 2 - 32 days). 
The diagnosis of clinically significant P. aeruginosa burn 
wound infection was confirmed with a positive wound swab in 
all patients. Seven patients also had positive blood cultures and 1 
had a positive urine culture. Thirteen of the 31 patients received 
systemic antibiotics. Systemic antibiotics were administered only 
to patients with systemic signs of sepsis, i.e. fever, tachycardia and 
leucocytosis; they included all those with positive blood or urine 
cultures. 
Bacteriology
In all patients with clinically significant P. aeruginosa burn 
wound infection, the resistance patterns of the isolates to 
antimicrobials were analysed: 61 isolates of P. aeruginosa were 
tested against systemic antimicrobials and 53 were tested against 
topical antimicrobials. The sensitivities of the 61 isolates tested 
against systemic antimicrobials are shown in Table 1. Apart from 
piperacillin-tazobactam (63.9%), ciprofloxacin and ceftazidine 
(80.3%) and cefepime (82.0%), the antimicrobial agents had >90% 
sensitivity. 
A multiresistant P. aeruginosa, defined as an organism resistant 
to three classes of antipseudomonal antimicrobials, was isolated in 
only 1 patient. This patient had no signs of systemic sepsis and did 
not receive systemic antimicrobials. In 22 patients the first isolate 
was sensitive to all systemic antipseudomonal antibiotics. Only 3 
were treated with systemic antibiotics. Isolates with resistance to 
systemic antimicrobials were cultured from 9 patients as the first 
positive wound swab. Four of these 9 patients received systemic 
antibiotics according to the sensitivities of the cultured isolates.
Table 1 also details the sensitivities of 53 isolates to topical 
antimicrobial agents. Notably, only 4 were sensitive to povidone-
iodine, but all were sensitive to chlorhexidine. 
Wound dressings and management
Table 2 summarises the dressings used for the management of 
the 31 patients with clinically significant P. aeruginosa wound 
infection. A total of 368 dressing days were needed until negative 
wound swabs were obtained, with an average of 12 dressing 
days per child (range 2 - 30 days). Sodium hypochlorite soaks 
followed by Flamazine dressings accounted for the vast majority 
of the dressings, with chlorhexidine being used when an organism 
resistant to Flamazine was isolated. Other dressings were used in 7 
patients for specific indications as decided by the senior surgeon in 
the unit.
Eleven children needed surgical debridement of wounds to help 
control P. aeruginosa infection, and of these 3 needed additional 
debridements. Fifty skin grafts were performed on 26 of the 
patients, with an average of 2 skin grafts per patient (range 1 - 4).
There was no relapse of P. aeruginosa infection after successful 
treatment of the wound infection.
Table 2. Dressing types and number of dressing days in patients with P. aeruginosa burn wound infection
Dressing type Patients,* n 
Dressing days
Total Average 
Sodium hypochlorite and Flamazine 28 278 15
Sodium hypochlorite and chlorhexidine 6 53 9
Bactigras 3 10 3
Acticoat 4 27 7
Total 31 368 12
* Six children treated with sodium hypochlorite and chlorhexidine were initially treated with sodium hypochlorite and Flamazine, until an organism resistant to Flamazine 
was isolated. Four children treated with Acticoat were later treated with sodium hypochlorite and Flamazine.
Table 1. Susceptibility of P. aeruginosa isolates associated 
with clinically significant burn wound infection
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Complications
Three patients had loss of Biobrane or allografts. Twenty-three 
cases of autologous skin graft loss occurred in 18 patients, 
with 5 needing two graft attempts. None of these patients had 
concomitant beta-haemolytic streptococcal wound infection. 
There were 45 theatre visits among 18 patients (mean 2.5 theatre 
visits per patient, range 1 - 5) for debridement of wounds after the 
diagnosis of P. aeruginosa infection was made. A cumulative total 
of 68 weeks were spent in hospital for management of the wound 
infections, at an average of 2 weeks per child (range 1 - 4 weeks). 
Discussion
P. aeruginosa infection in burns patients is responsible for 
significant morbidity.[1,2,8] In this study, we documented the 
incidence of P. aeruginosa burn wound infection at RCH and its 
impact on burn wound management.
The average TBSA of burn wounds in the children with P. 
aeruginosa infection in our study was 27%, and the average time 
spent in hospital before diagnosis of P. aeruginosa infection was 10 
days. This is in keeping with the findings of other authors (7 - 15 
days).[5,8,14,15] 
In this study the rate of P. aeruginosa wound colonisation was 
14.5%. This is at the lower end of the spectrum reported in the 
reviewed literature (11 - 74%).[2-5,7,10,11,14-16] It is unclear from the 
definitions and methods used why there should be such a variation 
in the incidence of wound colonisation between different burns 
units. Possible explanations include different patient loads, nurse/
patient ratios, sampling protocols, unit architecture, and cleaning 
and hygiene practices. 
All but 4 of the isolates of P. aeruginosa cultured from our patients 
were resistant to povidone-iodine, whereas all were sensitive to 
chlorhexidine. P. aeruginosa resistant to Flamazine was cultured 
from 6 patients. No other publications on the sensitivities of P. 
aeruginosa to topical antimicrobials in other burns units were found. 
The high incidence of resistance to povidone-iodine has resulted 
in a change of practice in our unit. Before this study, non-infected 
burn wounds were dressed with povidone-iodine-impregnated 
paraffin gauze swab dressings (Inadine). We now use chlorhexidine-
impregnated paraffin gauze swab dressings (Bactigras).
The proportion of patients developing clinically significant P. 
aeruginosa burn wound infection in our unit during the 36-month 
study period was 1.3%. This is lower than the 7.2% and 13% 
reported in the literature.[2,12] In the study by Rogers et al.,[12] 
the average TSBA burned was 15%, compared with 27% in our 
review. We believe that this reflects on the efficacy of the standard 
management protocols and infection control practices in our unit, 
as well as the dedication of our nurses.
Compared with the reported susceptibility of P. aeruginosa to 
antimicrobials in the burns literature reviewed, we found a low 
prevalence of resistance of the organism to systemic antibiotics 
(Table 3).[7,10,11,15,16] This may be due to the infrequent use of 
systemic antibiotics in our unit. Systemic antibiotics are only 
prescribed for patients with systemic signs of sepsis. 
One of the most dreaded non-lethal complications for a burn 
patient is graft loss. P. aeruginosa is a major cause of graft loss, 
and occurred in 23 of our 31 patients with clinically significant 
infection. Nine patients lost more than one attempted graft. In 
all patients who lost skin grafts, the diagnosis of P. aeruginosa 
infection was made after the initial skin grafting. Re-grafting was 
only done after negative wound swabs were obtained. There was 
no relapse of P. aeruginosa infection after successful treatment of 
the burn wound infection.
Conclusion
The incidence of clinically significant P. aeruginosa burn wound 
infection is low in our unit, attesting to the use of well-monitored 
infection control protocols. Despite effective wound therapy 
for P. aeruginosa, the morbidity stemming from graft loss and 
re-grafting is significant. We observed very high resistance to 
topical povidone-iodine, which has led to a change of practice. 
Resistance to systemic antimicrobials is lower than reported 
from other burns units, and this may be because their use as 
an adjunct to wound care is restricted to patients with systemic 
sepsis. Vigilance on the part of the clinical team treating a 
child with thermal injuries is necessary in order to diagnose P. 
aeruginosa burn wound infection early. Management protocols 
should be based on regular local audits of the resistance patterns 
of this troublesome organism. 
Table 3. Resistance patterns (%) of P. aeruginosa to systemic antibiotics reported in the literature
Antimicrobial













Ciprofloxacin 53 59 11 17 54 80
Ceftazidime 51 46 48 82 NS 80
Cefepime 49 NS NS NS NS 82
Tobramycin NS NS NS 72 NS 97
Gentamicin 49 20 31 53 NS 92
Amikacin 87 69 48 73 72 92
Piperacillin-tazobactam 53 36 31 60 65 64
Imipenem 60 48 NS NS NS 90
Meropenem NS NS NS NS NS 93
NS = not stated.
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